BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20435115)

  • 1. N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a novel delivery system for parathyroid hormone-related protein 1-34.
    Zhao SH; Wu XT; Guo WC; Du YM; Yu L; Tang J
    Int J Pharm; 2010 Jun; 393(1-2):268-72. PubMed ID: 20435115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and modification of N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier.
    Xu Y; Du Y; Huang R; Gao L
    Biomaterials; 2003 Dec; 24(27):5015-22. PubMed ID: 14559015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of chitosan quaternary ammonium salt and its application as drug carrier for ribavirin.
    Li SD; Li PW; Yang ZM; Peng Z; Quan WY; Yang XH; Yang L; Dong JJ
    Drug Deliv; 2014 Nov; 21(7):548-52. PubMed ID: 24215307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
    Lin CC; Lin CW
    Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholic acid modified N-(2-hydroxy)-propyl-3-trimethylammonium chitosan chloride for superoxide dismutase delivery.
    Cheng Y; Cai H; Yin B; Yao P
    Int J Pharm; 2013 Sep; 454(1):425-34. PubMed ID: 23830946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and characterization of N-(2-hydroxy)propyl-3-trimethyl ammonium chitosan chloride for potential application in gene delivery.
    Xiao B; Wan Y; Wang X; Zha Q; Liu H; Qiu Z; Zhang S
    Colloids Surf B Biointerfaces; 2012 Mar; 91():168-74. PubMed ID: 22104403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate.
    Wu Y; Yang W; Wang C; Hu J; Fu S
    Int J Pharm; 2005 May; 295(1-2):235-45. PubMed ID: 15848008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
    Chen F; Zhang ZR; Huang Y
    Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
    Gan Q; Wang T; Cochrane C; McCarron P
    Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
    Liu J; Gong T; Wang C; Zhong Z; Zhang Z
    Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.
    Singh KH; Shinde UA
    Pharmazie; 2011 Aug; 66(8):594-9. PubMed ID: 21901982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.
    Sarmento B; Ferreira DC; Jorgensen L; van de Weert M
    Eur J Pharm Biopharm; 2007 Jan; 65(1):10-7. PubMed ID: 17101268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
    Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
    Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of anti-neuroexcitation peptide (ANEP) loaded N-trimethyl chitosan chloride nanoparticles for brain-targeting.
    Wang S; Jiang T; Ma M; Hu Y; Zhang J
    Int J Pharm; 2010 Feb; 386(1-2):249-55. PubMed ID: 19900520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly(L-aspartic acid)-polyethylene glycol for controlled protein release.
    Shu S; Zhang X; Teng D; Wang Z; Li C
    Carbohydr Res; 2009 Jul; 344(10):1197-204. PubMed ID: 19508912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of amphiphilic chitosan derivatives as a nano-carrier for paclitaxel delivery.
    Zhou H; Liu X; Guo X; Li N; Yu W; Zhang Y; Ma X
    J Control Release; 2011 Nov; 152 Suppl 1():e124-5. PubMed ID: 22195795
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular fusion and whitening effect of a chitosan derivative coated liposome.
    Wang YW; Jou CH; Hung CC; Yang MC
    Colloids Surf B Biointerfaces; 2012 Feb; 90():169-76. PubMed ID: 22056083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins.
    Hu B; Pan C; Sun Y; Hou Z; Ye H; Zeng X
    J Agric Food Chem; 2008 Aug; 56(16):7451-8. PubMed ID: 18627163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain.
    Pillay S; Pillay V; Choonara YE; Naidoo D; Khan RA; du Toit LC; Ndesendo VM; Modi G; Danckwerts MP; Iyuke SE
    Int J Pharm; 2009 Dec; 382(1-2):277-90. PubMed ID: 19703530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.